Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076182 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Natalie K Binder und 6 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutics Discovery and Vascular Function in Pregnancy Laboratory, Heidelberg, VIC 3084, Australia. Hauptthemen laut MEDLINE: Pre-Eclampsia, Cardiovascular Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, The National Health Medical Research Council.
Abstract (Originalsprache)
Preeclampsia is associated with an increased lifelong risk of cardiovascular disease (CVD). It is not clear whether this is induced by persistent systemic organ and vascular damage following preeclampsia or due to a predisposition to both conditions that share cardiovascular pathophysiology. Common to both CVD and preeclampsia is the dysregulation of corin and its proteolytic product, atrial natriuretic peptide (ANP). ANP, a hypotensive hormone converted from pro-ANP by corin, is involved in blood pressure homeostasis. While corin is predominantly a cardiac enzyme, both corin and pro-ANP are significantly upregulated in the gravid uterus and dysregulated in preeclampsia. Relatively little is known about ANP function in the endothelium during a pregnancy complicated by preeclampsia. Here, we investigated the effect of ANP on endothelial cell proliferation and migration, markers of endothelial dysfunction, and receptor expression in omental arteries exposed to circulating preeclamptic toxins. ANP receptor expression is significantly upregulated in preeclamptic vasculature but not because of exposure to preeclampsia toxins tumour necrosis factor α or soluble fms-like tyrosine kinase-1. The supplementation of endothelial cells with ANP did not promote proliferation or migration, nor did ANP improve markers of endothelial dysfunction. The role of ANP in preeclampsia is unlikely to be via endothelial pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Therapeutics Discovery and Vascular Function in Pregnancy Laboratory, Heidelberg, VIC 3084, Australia.
- Department of Obstetrics and Gynaecology, University of Melbourne, Heidelberg, VIC 3084, Australia.
- Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
- Diagnostics Discovery and Reverse Translation Laboratory, Heidelberg, VIC 3084, Australia.
ORCID-Profile: Natalie K Binder, Natasha de Alwis, Bianca R Fato
Förderung
- National Health and Medical Research Council
- The National Health Medical Research Council
Zitieren
APA
Binder, N. K., Beard, S., de Alwis, N., Fato, B. R., Nguyen, T. V., Kaitu'u-Lino, T. J., & Hannan, N. J. (2023). Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076182
Vancouver
Binder NK, Beard S, de Alwis N, Fato BR, Nguyen TV, Kaitu'u-Lino TJ, et al. Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076182
BibTeX
@article{Binder2023,
author = {Binder, Natalie K and Beard, Sally and de Alwis, Natasha and Fato, Bianca R and Nguyen, Tuong-Vi and Kaitu'u-Lino, Tu'uhevaha J and Hannan, Natalie J},
title = {Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076182}
}
EUVIMED